Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26FD834
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,012
Award facts
- Contract value 100% obligated
- $11,012.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,012.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2mL pen format. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its extensive network to supply brand-name and generic medications across multiple therapeutic domains.
This delivery order falls under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical support to military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements through firm fixed-price delivery orders ranging from small transactions to substantial orders exceeding $45,000. Cosentyx, used for autoimmune conditions including psoriasis and rheumatoid arthritis, represents the type of specialized pharmaceutical commodity that supports the Defense Health Agency and broader military healthcare infrastructure globally.
Quick answers
Who was awarded contract SPE2DR26FD834?
SPE2DR26FD834 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FD834 worth?
The government has obligated $11,012 on SPE2DR26FD834.
Is contract SPE2DR26FD834 an order under another contract?
Yes. SPE2DR26FD834 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD834 competed?
The extent of competition for SPE2DR26FD834 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award